Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

What to consider when building a channel strategy for a rare disease product

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2022

Animal Health

How Destination Pet redefined practice autonomy for its financial benefit

MWI Animal Health
June 2022

Manufacturers

Nine questions about rare and orphan drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2022

Manufacturers

Working with government entities to advance access, affordability, and supply chain stability

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2021

Manufacturers

Webinar: Rethink your commercialization strategy

Donna Gilbert; Nancy Hoak
Biopharma Services
September 2021
Manufacturer commercialization Services

Pharmacies

Four things large retail pharmacies should look for in a distribution partner

Michael Amante
AmerisourceBergen
August 2021

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
optimal cell and gene therapy supply chain and tracking outcomes

Pharmacies

Five ways distributors should dream big for pharmacy partners

George Rafferty
AmerisourceBergen
June 2021

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Inverted color AmerisourceBergen icon
Innomar Strategies
June 2021

Manufacturers

The essential guide to drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2021

Physician Practices

Supporting flu vaccine access

Tim Navin
April 2021
Woman getting vaccine

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Commercializing rare and orphan disease products

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021

Manufacturers

Post-launch checklist: What to look for in a commercialization partner

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Post-launch checklist

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Strategic partnerships for unlocking product potential ebook

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2021
Considerations for the commercialization of cell and gene therapies

Manufacturers

How to make the most of integrated commercialization solutions

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2021
AmerisourceBergen manufacturer commercialization strategies

Manufacturers

Ebook: Virtual drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
November 2020

Manufacturers

The road to a COVID-19 treatment launch

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2020

Manufacturers

Five growth drivers for the consumer healthcare products market

Jessica Donati
Strategic Global Sourcing at AmerisourceBergen
October 2020
consumer scanning products on smartphone in store

Manufacturers

Infographic: navigating health policy

Inverted color AmerisourceBergen icon
AmerisourceBergen
October 2020

Pharmacies

Spotlight: The corporate partnerships model

George Rafferty
AmerisourceBergen
August 2020

Pharmacies

Driving deeper customer relationships

Michael Amante
AmerisourceBergen
July 2020

Physician Practices

How Community and Specialty Physician Practices Are Confronting COVID-19 Challenges

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2020
Doctor on video call with colleagues

Pharmacies

How Do Allocations Work for the Pharma Supply Chain?

Heather Zenk
Heather Zenk, RPh, PharmD
AmerisourceBergen
April 2020

Manufacturers

How the Pharma Supply Chain is Responding to COVID-19

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2020

Manufacturers

Preparing for DSCSA Interoperability

AmerisourceBergen icon
Matt Sample
AmerisourceBergen
May 2019

Phase II of DSCSA requires interoperable systems for the electronic tracking of product through the supply chain. Is pharma prepared? Learn what stakeholders need to know and do know to prepare for 2023.

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2018

How manufacturers can benefit from provider-led care coordination to improve patient outcomes.

Health Systems

Commercially Available Unit Dose Products: Enhancing Access to Treatments and Promoting Pharmacy Efficiency

Brian McMillan
American Health Packaging
May 2018

While suppliers are making fewer pre-packaged unit dose treatments available, health system pharmacies still have options for acquiring them. Learn which is best.

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2018

How is manufacturer thinking around channel strategy changing for oral oncolytics?

Manufacturers

Improving Customer Experience and Driving Long-Term Value for Manufacturers

Rich Tremonte
AmerisourceBergen
August 2017

Rich Tremonte on the current healthcare landscape, the role of the wholesaler and how the new organizational structure at AmerisourceBergen brings out the best in both.

Manufacturers

Changing Channels

Donna Gilbert
Biopharma Services
April 2017

Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.